A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents (Q64663096)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents |
clinical trial |
Statements
An Open-Label Phase 1/2 Study to Assess the Immunogenicity and Safety of Two Different Dose Levels of H1N1 Pandemic Influenza Vaccine in Healthy Infants, Children and Adolescents Aged 6 Months to 17 Years (English)
0 references
September 2009
0 references
April 2010
0 references
400
0 references
6 month
0 references
17 year
0 references